Venture-Backed Startups
130,795 companies with verified investor relationships.
0 investors
0 investors
1 investor
0 investors
Cypress provides a testing framework and automation tools for developers to build and test web applications more efficiently and reliably.
9 investors
0 investors
0 investors
0 investors
Cypress Five Star Inc operates fast casual restaurant franchises, including Blaze Pizza and Five Guys locations across Canada and the United States. The company has run these food service outlets since 2010.
1 investor
Cypris provides AI-powered patent intelligence and IP research tools for R&D and intellectual property teams, enabling them to analyze patent landscapes, assess freedom-to-operate risks, and conduct competitive intelligence across over 180 million patents globally combined with scientific literature and market data.
3 investors
Cypris Medical develops minimally-invasive medical devices and treatments designed specifically for plastic surgeons to deliver results comparable to traditional surgery with shorter recovery times. The company combines medical device expertise with input from practicing surgeons to address unmet needs in the plastic surgery market.
0 investors
Cyprium Therapeutics develops therapies for rare genetic diseases, with a focus on treatments for Menkes disease. The company's pipeline includes ZYCUBO (copper histidinate) and AAV-ATP7A gene therapy candidates.
0 investors
MetLife Cyprus is the local operation of insurance provider MetLife, offering insurance products and customer service to clients in Cyprus.
1 investor
0 investors
Cyral provides agentless database security monitoring across cloud, on-premises, and SaaS environments. The platform detects and blocks suspicious database access, discovers sensitive data, and automatically remediates security misconfigurations.
1 investor
0 investors
Develops regenerative therapy for persistent smell loss, currently in Phase 2 clinical trials.
1 investor
Cyrano Therapeutics is a clinical-stage regenerative medicine company developing CYR-064, a nasal therapy for post-viral smell loss (hyposmia) and associated loss of taste. It serves patients with anosmia and is advancing its lead candidate through clinical trials toward Phase 3.
1 investor
Cyrano is a brand-building platform that handles behind-the-scenes operations—investing, building, launching, operating, and scaling—for creators and brand founders. It positions itself as an operational engine for modern consumer brands.
1 investor
Cyrano Video provides subscription-based video production services combining customized hardware, software, and editorial support for healthcare organizations. The platform enables clients to produce video content at scale across multiple formats—in-studio, at-desk, and mobile—for enhanced internal communication, patient engagement, and personalized outreach.
1 investor
Cyrcadia Health develops technology based on circadian rhythm science to detect tissue disruption and cancer risk. The company's core innovation relates circadian clock dysregulation to cancer development and prognosis.
0 investors
Cyrebro Neurosignals develops a neurotechnology platform using EEG and AI to analyze brain activity in real time, providing digital neuromarkers for healthcare applications and consumer product development. The platform serves healthcare professionals, clinical researchers, and consumer product companies in mental health, neurological treatment, and product optimization.
1 investor
CYREBRO provides digital forensic investigation and security operations center (SOC) services for enterprises, including threat detection, incident response, and threat hunting to minimize the impact of cyberattacks.
3 investors
CyrenCare provides digital patient intake software that captures clinical information through customizable forms and generates clinician-friendly reports for healthcare providers. The platform supports multilingual service delivery.
1 investor